Crossmark

ASURE Clinical Trial Protocol: A Randomized, Placebo-Controlled, Proof-of-Concept Study Aiming to Evaluate Safety and Target Engagement following Administration of TW001 in Early Alzheimer's Disease Patients

Crossref DOI link: https://doi.org/10.14283/jpad.2023.107

Published Print: 2023-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Oosthoek, Marlies

Lili, A.

Almeida, A.

van Loosbroek, O.

van der Geest, R.

de Greef-van der Sandt, I.

van Bokhoven, P.

Sikkes, S.A.M.

Teunissen, C.E.

Vijverberg, E.G.B.
License Information

Text and Data Mining valid from 2023-11-01

Text and Data Mining valid from 2023-11-01

Version of Record valid from 2023-10-24
More Information

This article is maintained by: Elsevier

Article Title: ASURE Clinical Trial Protocol: A Randomized, Placebo-Controlled, Proof-of-Concept Study Aiming to Evaluate Safety and Target Engagement following Administration of TW001 in Early Alzheimer's Disease Patients

Journal Title: The Journal of Prevention of Alzheimer's Disease

CrossRef DOI link to publisher maintained version: https://doi.org/10.14283/jpad.2023.107

Content Type: article

Copyright: Copyright © 2023 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS

Document is current

Any future updates will be listed below